In today’s briefing:
- JD.com (JD): Plunged Following Indexes, But 4Q21 Result Worth Buying
- STAR50 Index Rebalance Preview (June): Back to the All Important Question
- Li Ning (2331): SWF Exclusion
- Green Tea Group IPO Preview
- Arrail IPO: Peer Comparison and Valuation
- Morning Views Asia: Fosun International, Times China, Yuzhou Group
JD.com (JD): Plunged Following Indexes, But 4Q21 Result Worth Buying
- Revenue grew rapidly by 23% in 4Q21 and we believe revenue will grow by 18% in 2022.
- We are not concerned about the zero net margin, because operating cash flows were still strong in 2021.
- We believe the stock has a price target of US$73, which is 18% over last closing price.
STAR50 Index Rebalance Preview (June): Back to the All Important Question
- There could be 3 or 5 changes to the STAR50 INDEX in June depending on the minimum listing history (6 months or 12 months) used by the index committee.
- Jinko Solar (688223 CH) is a high probability inclusion while Shanghai Microport Endovascular MedTech (688016 CH), ArcSoft Corp Ltd (688088 CH) and DBAPP Security Ltd (688023) are high probability deletions.
- The March rebalance will be implemented at the close tomorrow. The adds have outperformed the deletes post announcement and there could be a reversal from next week.
Li Ning (2331): SWF Exclusion
- Norges Bank excludes Li Ning (2331 HK) from its list due to poor labor practices/human rights issues.
- Today’s share price could be a telltale sign of the near-term prospect, down when the majority are up.
- Will the other international shareholders follow suit on dumping the shares because of the human rights abuse? Potentially yes.
Green Tea Group IPO Preview
- Green Tea Group (GT HK) received the Hong Kong Stock Exchange approval to launch its IPO on 7th March 2022, almost a year after filing its first application.
- The company expects to raise around US$100-200m via an IPO jointly sponsored by Citi and CMB International.
- Growth prospects look decent with plans to open 75-100 new restaurants each year. However, We aren’t excited about the IPO as the Company’s business model seems significantly weaker than peers.
Arrail IPO: Peer Comparison and Valuation
- Arrail, the largest dental services provider in China’s premium dental service market has announced the terms for its IPO.
- The company plans to raise net proceeds of approx. HK$590m (US$75.9m) through issuing 46.5m at a price of HK$14.62 per share.
- Cornerstone investors have agreed to purchase approx. US$65m worth of shares and these investors include Abax, Harvest, Hudson Bay, OrbiMed and TVHKL.
Morning Views Asia: Fosun International, Times China, Yuzhou Group
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.
Before it’s here, it’s on Smartkarma